Search Results - "Castell, D O"

Combined multichannel intraluminal impedance-pH monitoring to select patients with persistent gastro-oesophageal reflux for laparoscopic Nissen fundoplication by Mainie, I., Tutuian, R., Agrawal, A., Adams, D., Castell, D. O.

“…Background: Combined multichannel intraluminal impedance‐pH (MII‐pH) monitoring detects gastro‐oesophageal reflux and identifies acid and non‐acid reflux…”
Get full text

Review article: an analysis of the efficacy, perforation rates and methods used in pneumatic dilation for achalasia by Katzka, D. A., Castell, D. O.

“…Aliment Pharmacol Ther 2011; 34: 832–839 Summary Background  Pneumatic dilation has re‐emerged as a first line treatment for achalasia, but conclusions are…”
Get full text

Classification of oesophageal motility abnormalities by SPECHLER, S J, CASTELL, D O

“…Manometric examination of the oesophagus frequently reveals abnormalities whose cause is unknown and whose physiological importance is not clear. A large body…”
Get full text

Baclofen decreases acid and non‐acid post‐prandial gastro‐oesophageal reflux measured by combined multichannel intraluminal impedance and pH by Vela, M. F., Tutuian, R., Katz, P. O., Castell, D. O.

“…Summary Background : Omeprazole controls acid but not non‐acid reflux. The GABA B agonist baclofen decreases acid reflux through the inhibition of transient…”
Get full text

Review article: the pathophysiology of gastro‐oesophageal reflux disease − oesophageal manifestations by Castell, D. O., Murray, J. A., Tutuian, R., Orlando, R. C., Arnold, R.

“…Summary The pathogenesis of gastro‐oesophageal reflux disease (GERD) is multifactorial, involving transient lower oesophageal sphincter relaxations (TLESRs) as…”
Get full text

Review article: oesophageal spasm – diagnosis and management by TUTUIAN, R., CASTELL, D. O.

“…Summary Oesophageal spasm is a common empiric diagnosis clinically applied to patients with unexplained chest pain. In contrast it is an uncommon manometric…”
Get full text

Viscous impedance is an important indicator of abnormal esophageal motility by Clayton, S. B., Rife, C., Kalbfleisch, J. H., Castell, D. O.

“…Background Non‐obstructive Dysphagia (NOD) is one of the most common symptoms evaluated using esophageal manometry. Although manometry is considered the gold…”
Get full text

Proton pump inhibitors: better acid suppression when taken before a meal than without a meal by Hatlebakk, J. G., Katz, P. O., Camacho‐Lobato, L., Castell, D. O.

“…Background: Proton pump inhibitors including omeprazole and lansoprazole inhibit gastric acid secretion by selectively and non‐competitively inactivating the…”
Get full text

Swallowing Activity Assessed by Ambulatory Impedance-pH Monitoring Predicts Awake and Asleep Periods at Night by Pohl, D., Arevalo, F., Singh, E., Freeman, J., Tutuian, R., Castell, D. O.

“…Introduction Voluntary muscle activity, including swallowing, decreases during the night. The association between nocturnal awakenings and swallowing activity…”
Get full text

Ranitidine controls nocturnal gastric acid breakthrough on omeprazole: A controlled study in normal subjects by Peghini, Paolo L., Katz, Philip O., Castell, Donald O.

“…Background & Aims: Proton pump inhibitors administered twice daily do not provide complete nocturnal acid suppression. Acid breakthrough, or decrease in…”
Get full text

Gastro‐oesophageal reflux associated with nocturnal gastric acid breakthrough on proton pump inhibitors by KATZ, P. O, ANDERSON, C, KHOURY, R, CASTELL, D. O

“…Background Nocturnal gastric acid breakthrough, defined as intragastric pH < 4 for more than 1 h in the overnight period, is observed in up to 70% of normal…”
Get full text

Bedtime H2 blockers improve nocturnal gastric acid control in GERD patients on proton pump inhibitors by Xue, S., Katz, P. O., Banerjee, P., Tutuian, R., Castell, D. O.

“…Aim: Proton pump inhibitors taken twice daily before meals (proton pump inhibitor b.d. AC) effectively controls daytime gastric pH; however, nocturnal gastric…”
Get full text

Intragastric acid suppression and pharmacokinetics of twice‐daily esomeprazole: a randomized, three‐way crossover study by Katz, P. O., Castell, D. O., Chen, Y., Andersson, T., Sostek, M. B.

“…Summary Background : Patients with refractory gastro‐oesophageal reflux disease, extra‐oesophageal reflux symptoms, Barrett's oesophagus, or Zollinger–Ellison…”
Get full text

Esophageal function testing using multichannel intraluminal impedance by Srinivasan, R, Vela, M F, Katz, P O, Tutuian, R, Castell, J A, Castell, D O

“…Multichannel intraluminal impedance (MII) is a new technique for evaluation of bolus transport. We evaluated esophageal function using bolus transport time…”
Get more information

Fundoplication eliminates chronic cough due to non-acid reflux identified by impedance pH monitoring by Mainie, I, Tutuian, R, Agrawal, A, Hila, A, Highland, K B, Adams, D B, Castell, D O

“…The symptoms of extra-oesophageal gastro-oesophageal reflux disease (GORD) (such as chronic cough and hoarseness) are traditionally more difficult to treat…”
Get full text

Nocturnal gastric acidity and acid breakthrough on different regimens of omeprazole 40 mg daily by HATLEBAKK, J. G, KATZ, P. O, KUO, B, CASTELL, D. O

“…Background On chronic intake of omeprazole, most healthy volunteers and patients still have nocturnal acid breakthrough (NAB), defined as night‐time periods…”
Get full text

The effects of tegaserod (HTF 919) on oesophageal acid exposure in gastro‐oesophageal reflux disease by Kahrilas, P. J., Quigley, E. M. M., Castell, D. O., Spechler, S. J.

“…Background: Tegaserod (HTF 919), a 5‐HT4 receptor partial agonist, has prokinetic effects that might be useful in decreasing acid reflux in gastro‐oesophageal…”
Get full text

Esomeprazole resolves chronic heartburn in patients without erosive oesophagitis by Katz, P. O., Castell, D. O., Levine, D.

“…Summary Background : Patients with chronic heartburn but with no endoscopic evidence of erosive oesophagitis require gastric acid suppression to relieve…”
Get full text

Histamine-2 receptor antagonists at night improve gastroesophageal reflux disease symptoms for patients on proton pump inhibitor therapy by Rackoff, A., Agrawal, A., Hila, A., Mainie, I., Tutuian, R., Castell, D. O.

“…While night‐time symptoms of gastroesophageal reflux disease (GERD) are common, considerable controversy exists regarding the use of histamine‐2 receptor…”
Get full text

Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring by Mainie, I, Tutuian, R, Shay, S, Vela, M, Zhang, X, Sifrim, D, Castell, D O

“…Background and aims: Empiric proton pump inhibitor (PPI) trials have become increasingly popular leading to gastroenterologists frequently evaluating…”
Get full text